Results 221 to 230 of about 41,337 (280)

A probiotic-drug cascade system for inflammatory bowel disease <i>via</i> tryptophan metabolism and gut microbiome remodeling. [PDF]

Acta Pharm Sin B
Yang J, Feng Z, Sun S, Pei T, Li Y, Xue B, Zhou C, Song Q, Zhang Y, Wang L.   +9 more
europepmc   +1 more source

Transporter-Drive Interstitial Tissue Exposure and Pharmacodynamic Response of Meropenem in Sepsis: A Mechanistic PBPK Modeling Study. [PDF]

CPT Pharmacometrics Syst Pharmacol
Olivo LB, de Lemos JLS, Rodrigues VJ, de Araújo BV.   +3 more
europepmc   +1 more source

Genomic Evolution of Myeloproliferative Neoplasms and Therapy-Associated Mutagenesis. [PDF]

Cancer Discov
Leongamornlert D, Lee J, Kamizela AE, To K, Myers D, Williams N, Nyamondo K, Wang X, Guo J, Dissanayake RK, Price J, Durrani AJ, Lambert J, Spencer Chapman M, Pimanda JE, Baxter EJ, Green AR, Godfrey AL, Nangalia J.   +18 more
europepmc   +1 more source

The Clinical and Phenotypic Significance of Sub-Threshold JAK2 V617F Signals in Patients Classified as JAK2 V617F-Negative. [PDF]

Curr Issues Mol Biol
Ünsal ŞE, Akalın H, Tan B, Polat Akyol G, Kiraz A.   +4 more
europepmc   +1 more source

Allele burden expansion in <i>JAK2</i> ^V617F and <i>CALR</i>-mutated myeloproliferative neoplasms predicts disease progression and is associated with anagrelide treatment. [PDF]

Hemasphere
Ng ZY, Cottin L, Demoy M, Luque Paz D, Orvain C, Lambert WC, Ianotto JC, Lippert E, Ross DM, Iarossi D, Khan A, Lock D, Truong C, Laribi K, Yang YF, Gagnon LL, Ugo V, Harrison CN, O'Sullivan J.   +18 more
europepmc   +1 more source

Single-cell long-read genotyping of transcripts reveals discrete mechanisms of clonal evolution in post-MPN AML. [PDF]

Blood Adv
Grabek J, Straube J, Cooper L, Haldar R, Zhang R, Dulige I, Barker M, Gatehouse W, Christensen H, Amor G, Ling VY, McNamara C, Ross DM, Perkins A, Bywater MJ, Lane SW.   +15 more
europepmc   +1 more source

Collagen Turnover Is Associated with Disease Severity, Bone Marrow Fibrosis, and the <i>JAK2V617F</i> Variant Allele Frequency in Myeloproliferative Neoplasms. [PDF]

Cancers (Basel)
Bistrup CN, Larsen MK, Junker P, Skov V, Kjær L, Knudsen TA, Karsdal M, Willumsen N, Hasselbalch HC.   +8 more
europepmc   +1 more source

CPX-351 in combination with ruxolitinib for advanced-phase myeloproliferative neoplasms: results of a phase 1 study. [PDF]

Blood Neoplasia
Handa S, Madanat Y, Pugh K, Dvorak-Kornaus K, Zhao Q, Mims A, Koenig K, Srisuwananukorn A, Cook R, Swords R, Borate U.   +10 more
europepmc   +1 more source

Comprehensive High-Sensitivity Mutation Profiling in MPNs: Diagnostic and Prognostic Implications. [PDF]

Cancers (Basel)
Kim N, Kang Y, Kook HW, Chung H, Jang JE, Lee ST, Song J, Kim JS, Choi JR, Cheong JW, Shin S.   +10 more
europepmc   +1 more source

Systemic inflammation response index and total cholesterol in relation to the occurrence of major adverse cardiovascular and cerebrovascular events in patients with myeloproliferative neoplasms. [PDF]

BMC Cardiovasc Disord
Wang C, Li Y.
europepmc   +1 more source